Skip to content

Influence of Ashi diabetes mellitus therapeutic schedule on hypoglycemic drugs in patients with type 2 diabetes mellitus

Influence of Ashi diabetes mellitus therapeutic schedule on hypoglycemic drugs in patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OIC-17012433
Enrollment
Unknown
Registered
2017-08-21
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Case series:project of AShi Diabetes

Sponsors

Beijing Bai Nian Fu Shou Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 70 years; 2. Consistent with the 1999 diagnostic criteria(WHO) for type diabetes mellitus; 3. HbA1c>7.5% nearly 1 months; 4. currently acceptance under Standardized of hypoglycemic drugs treatment; 5. Subject to informed consent, willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes or specific type of diabetes Patients with more than 2 episodes of hypoglycemia and 3 times higher blood sugar values than those with low blood sugar levels in the past 1 months; 2. Pregnant or prepar for pregnant or lactating; 3. People with mental disorders, cognitive impairment, or uncooperative patients; 4. There were complications of severe diabetes mellitus (Hyperplastic retinopathy the severity is more than that of stage IV nephropathy or creatinine>2mg/dl or 177µmol/L NYHA class III diabetic footclass I); 5. Combined with systemic diseases such as heart, brain, liver and hematopoietic system or Other serious diseases that affect the quality of life; 6. Patient who was suffering from hepatitis B and other infectious diseases; 7. Patients who are participating in other studies.

Design outcomes

Primary

MeasureTime frame
venous blood glucose;

Secondary

MeasureTime frame
Seven times the blood sugar;glycosylated hemoglobin;glycated serum protein GSP;Blood sugar before and after breakfast;diabetes self-efficacy scale(DSES);

Countries

China

Contacts

Public ContactXiangming Wen

Beijing Bai Nian Fu Shou Academy of Traditional Chinese Medicine

wxm7835@163.com+86 13911717835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026